NCT03998293View on ClinicalTrials.gov

Direct Measurement of Proinsulin Clearance in Humans

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Healthy
Interventions
DRUG

Somatostatin

infused to block endogenous insulin secretion over a 4 hour period

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Mayo Clinic

OTHER

NCT03998293 - Direct Measurement of Proinsulin Clearance in Humans | Biotech Hunter | Biotech Hunter